Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GKOS Glaukos Corp

未开盘 11-22 16:00:00 EST

144.00

+3.17

+2.25%

盘后144.00

+0.000.00%

16:08 EST

最高146.09	最低141.18	成交量54.90万
今开141.18	昨收140.83	日振幅3.48%
总市值79.36亿	流通市值76.81亿	总股本5,511万
成交额7,920万	换手率1.03%	流通股本5,334万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GKOS","market":"US","secType":"STK","nameCN":"Glaukos Corp","latestPrice":144,"timestamp":1732309200000,"preClose":140.83,"halted":0,"volume":549002,"hourTrading":{"tag":"盘后","latestPrice":144,"preClose":144,"latestTime":"16:08 EST","volume":9044,"amount":1302333.552,"timestamp":1732309716206},"delay":0,"floatShares":53338129,"shares":55109429,"eps":-2.928572,"marketStatus":"未开盘","marketStatusCode":0,"change":3.17,"latestTime":"11-22 16:00:00 EST","open":141.18,"high":146.085,"low":141.18,"amount":79202772.71364,"amplitude":0.034829,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.928572,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1435204800000,"adjPreClose":140.83,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":143,"preClose":140.83,"latestTime":"07:46 EST","volume":12,"amount":1690.94004,"timestamp":1732279611711},"postHourTrading":{"tag":"盘后","latestPrice":144,"preClose":144,"latestTime":"16:08 EST","volume":9044,"amount":1302333.552,"timestamp":1732309716206},"volumeRatio":1.5680601308071482,"impliedVol":0.383,"impliedVolPercentile":0.0876},"requestUrl":"/m/hq/s/GKOS/wiki","defaultTab":"wiki","newsList":[{"id":"2484795971","title":"Glaukos Corporation盘中异动 大幅拉升5.16%报144.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484795971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484795971?lang=zh_cn&edition=full","pubTime":"2024-11-20 02:52","pubTimestamp":1732042341,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日02时52分，Glaukos Corporation股票出现异动，股价快速拉升5.16%。截至发稿，该股报144.05美元/股，成交量15.7891万股，换手率0.29%，振幅5.84%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.24%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120025221abcfdcbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120025221abcfdcbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","IE0009354923.USD","GKOS","LU1878469433.USD","BK4082"],"gpt_icon":0},{"id":"2482427154","title":"Glaukos Corporation2024财年第三财季实现净利润-21.41百万美元，同比增加29.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482427154","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482427154?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:03","pubTimestamp":1731168210,"startTime":"0","endTime":"0","summary":"11月10日，Glaukos Corporation公布财报，公告显示公司2024财年第三财季净利润为-21.41百万美元，同比增加29.66%；其中营业收入为96.67百万美元，同比增加23.86%，每股基本收益为-0.39美元。从资产负债表来看，Glaukos Corporation总负债2.58亿美元，其中短期债务0.00美元，资产负债比为3.60，流动比率为0.06。机构评级：截至2024年11月10日，当前有11家机构对Glaukos Corporation目标价做出预测，其中目标均价为139.82美元，其中最低目标价为115.00美元，最高目标价为155.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000429abb101b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000429abb101b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS"],"gpt_icon":0},{"id":"2481989801","title":"Glaukos Corporation盘中异动 股价大涨5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481989801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481989801?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:32","pubTimestamp":1730903550,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时32分，Glaukos Corporation股票出现波动，股价快速拉升5.48%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为1.63%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。它提供iStent，一种微型旁路支架，可与白内障手术配合插入，以降低成年人轻度至中度开角型青光眼患者的眼内压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622323098e40dbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622323098e40dbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009354923.USD","GKOS","BK4082","LU1878469433.USD","BK4548"],"gpt_icon":0},{"id":"2481889946","title":"Glaukos Corporation盘中异动 快速跳水5.14%报124.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481889946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481889946?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:33","pubTimestamp":1730817219,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时33分，Glaukos Corporation股票出现波动，股价大幅下跌5.14%。截至发稿，该股报124.63美元/股，成交量1.4924万股，换手率0.03%，振幅0.37%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为0.20%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223339aba23c8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223339aba23c8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS","LU1878469433.USD","BK4548","IE0009354923.USD","BK4082"],"gpt_icon":0},{"id":"2481541559","title":"美国研究综述-信诺、万豪、拉尔夫-劳伦","url":"https://stock-news.laohu8.com/highlight/detail?id=2481541559","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481541559?lang=zh_cn&edition=full","pubTime":"2024-11-05 15:04","pubTimestamp":1730790257,"startTime":"0","endTime":"0","summary":"    路透11月5日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Cigna、万豪和 Ralph Lauren。要闻             * Cigna   ：Piper Sandler将目标价从392美元上调至394美元             * 万豪  ：杰富瑞将目标价从 225 美元上调至 251 美元              * Ralph Lauren Corp   ：TD Cowen 将目标价从 208 美元上调至 251 美元              * Vertex Pharmaceuticals Inc   ：丰业银行将目标价从480美元上调至486美元             * Wynn Resorts Ltd   ：摩根大通将目标价从101美元上调至113美元  以下是路透周二报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSTL","LU0149725797.USD","SM","FIS","EVER","LU0266512127.USD","EGHT","HIMS","FOXA","BK4106","IRON","LU0320765489.SGD","LU1489326972.SGD","RZLT","BWIN","ST","NMRA","SHAK","SLAB","IE00BZ1G4Q59.USD","LSCC","BMRN","GKOS","LU","ATUS","PTGX","LU0949170772.SGD","RL","NYT","AMG","BEN","KROS","CAMP","FRPT","CI","EDIT","LU0971096721.USD","LU1244550221.USD","ARES","ILMN","AWI","MAR","CMS","LU1363072403.SGD","INSP","OMI","MDGL"],"gpt_icon":1},{"id":"2481415545","title":"美国研究综述-信诺、万豪、拉尔夫-劳伦","url":"https://stock-news.laohu8.com/highlight/detail?id=2481415545","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481415545?lang=zh_cn&edition=full","pubTime":"2024-11-05 15:04","pubTimestamp":1730790257,"startTime":"0","endTime":"0","summary":"    路透11月5日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Cigna、万豪和 Ralph Lauren。要闻             * Cigna   ：Piper Sandler将目标价从392美元上调至394美元             * 万豪  ：杰富瑞将目标价从 225 美元上调至 251 美元              * Ralph Lauren Corp   ：TD Cowen 将目标价从 208 美元上调至 251 美元              * Vertex Pharmaceuticals Inc   ：丰业银行将目标价从480美元上调至486美元             * Wynn Resorts Ltd   ：摩根大通将目标价从101美元上调至113美元  以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVER","FRPT","KROS","IE00BZ1G4Q59.USD","SM","LU","NMRA","LU1363072403.SGD","OMI","SHAK","FIS","CAMP","ATUS","RZLT","ST","AWI","RL","ARES","LU1244550221.USD","PTGX","LU0971096721.USD","CMS","LSCC","LU0266512127.USD","BWIN","AMG","EGHT","LU0320765489.SGD","BMRN","GKOS","IRON","LU0149725797.USD","NYT","SLAB","LU1489326972.SGD","ILMN","LU0949170772.SGD","CI","MDGL","BEN","EDIT","MAR","FOXA","CSTL","INSP","BK4106"],"gpt_icon":1},{"id":"2480378051","title":"Glaukos Corporation盘中异动 下午盘大幅下跌5.01%报131.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480378051","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480378051?lang=zh_cn&edition=full","pubTime":"2024-11-01 01:20","pubTimestamp":1730395244,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日01时20分，Glaukos Corporation股票出现异动，股价大幅下挫5.01%。截至发稿，该股报131.73美元/股，成交量32.4407万股，换手率0.59%，振幅4.73%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为0.59%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。它提供iStent，一种微型旁路支架，可与白内障手术配合插入，以降低成年人轻度至中度开角型青光眼患者的眼内压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101012044971a39c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101012044971a39c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009354923.USD","LU1878469433.USD","BK4548","BK4082","GKOS"],"gpt_icon":0},{"id":"2468968505","title":"Glaukos Corporation盘中异动 下午盘急速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468968505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468968505?lang=zh_cn&edition=full","pubTime":"2024-09-20 02:10","pubTimestamp":1726769439,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日02时10分，Glaukos Corporation股票出现波动，股价快速上涨5.11%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.94%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。它提供iStent，一种微型旁路支架，可与白内障手术配合插入，以降低成年人轻度至中度开角型青光眼患者的眼内压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920021039a1db39cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920021039a1db39cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","IE0009354923.USD","BK4082","LU1878469433.USD","GKOS"],"gpt_icon":0},{"id":"2458346271","title":"Glaukos Corporation盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458346271","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458346271?lang=zh_cn&edition=full","pubTime":"2024-08-08 23:50","pubTimestamp":1723132208,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日23时50分，Glaukos Corporation股票出现异动，股价急速上涨5.05%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为1.48%。其相关个股中，Nexalin Technology Inc C/Wts 、Clearpoint Neuro Inc.、Axogen, Inc.涨幅较大，Outset Medical, Inc.、Bone Biologics Corp、Silk Road Medical, Inc.较为活跃，换手率分别为15.61%、10.81%、7.46%，振幅较大的相关个股有Elutia, Inc.、Rapid Micro Biosystems, Inc.、Lensar, Inc.，振幅分别为38.56%、25.33%、24.15%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808235008941ff7f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808235008941ff7f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS","LU1878469433.USD","BK4548","BK4082","IE0009354923.USD"],"gpt_icon":0},{"id":"2457753550","title":"Glaukos Corporation2024财年第二财季实现净利润-50.55百万美元，同比减少54.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457753550","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457753550?lang=zh_cn&edition=full","pubTime":"2024-08-05 00:17","pubTimestamp":1722788273,"startTime":"0","endTime":"0","summary":"8月5日，Glaukos Corporation公布财报，公告显示公司2024财年第二财季净利润为-50.55百万美元，同比减少54.07%；其中营业收入为95.69百万美元，同比增加19.02%，每股基本收益为-1.00美元。从资产负债表来看，Glaukos Corporation总负债2.55亿美元，其中短期债务0.00美元，资产负债比为3.61，流动比率为0.06。机构评级：截至2024年8月5日，当前有12家机构对Glaukos Corporation目标价做出预测，其中目标均价为133.42美元，其中最低目标价为115.00美元，最高目标价为145.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805001801957caac8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805001801957caac8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS"],"gpt_icon":0},{"id":"2456335592","title":"Glaukos Corporation盘中异动 快速跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456335592","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456335592?lang=zh_cn&edition=full","pubTime":"2024-08-02 22:36","pubTimestamp":1722609396,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日22时36分，Glaukos Corporation股票出现异动，股价急速下跌5.06%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为1.12%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。消息层面，截至22时36分，《富国银行：维持Glaukos评级，由增持调整至增持评级,目标价由120.00美元调》资讯为影响Glaukos Corporation的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802223636aefcfb8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802223636aefcfb8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS","IE0009354923.USD","LU1878469433.USD","BK4082","BK4548"],"gpt_icon":0},{"id":"2456543934","title":"富国银行：维持Glaukos(GKOS.US)评级，由增持调整至增持评级,目标价由120.00美元调","url":"https://stock-news.laohu8.com/highlight/detail?id=2456543934","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456543934?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:55","pubTimestamp":1722520527,"startTime":"0","endTime":"0","summary":"富国银行 ：维持Glaukos(GKOS.US)评级，由增持调整至增持评级,目标价由120.00美元调整至135.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408012207459f05c1d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408012207459f05c1d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS"],"gpt_icon":0},{"id":"2456336214","title":"Glaukos Corporation盘中异动 早盘股价大跌8.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456336214","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456336214?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:31","pubTimestamp":1722519087,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日21时31分，Glaukos Corporation股票出现异动，股价急速下挫8.01%。截至发稿，该股报107.79美元/股，成交量3.0123万股，换手率0.06%，振幅2.96%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.71%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。它提供iStent，一种微型旁路支架，可与白内障手术配合插入，以降低成年人轻度至中度开角型青光眼患者的眼内压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408012131279f05af9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408012131279f05af9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009354923.USD","BK4548","GKOS","BK4082","LU1878469433.USD"],"gpt_icon":0},{"id":"2456031461","title":"Needham：维持Glaukos(GKOS.US)评级，由买入调整至买入评级, 目标价由131.00美元调整至137.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2456031461","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456031461?lang=zh_cn&edition=full","pubTime":"2024-08-01 17:31","pubTimestamp":1722504717,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE0009354923.USD","GKOS","BK4082","LU1878469433.USD","BK4548"],"gpt_icon":0},{"id":"2456819176","title":"美国研究综述-CH Robinson Worldwide、Lam Research、Meta","url":"https://stock-news.laohu8.com/highlight/detail?id=2456819176","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456819176?lang=zh_cn&edition=full","pubTime":"2024-08-01 15:42","pubTimestamp":1722498176,"startTime":"0","endTime":"0","summary":"    路透8月1日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 CH Robinson Worldwide、Lam Research 和 Meta。要闻             * CH Robinson Worldwide Inc   ：摩根大通将其评级从中性上调至增持             * Lam Research Corp   ：TD Cowen将目标价从1000美元上调至1050美元              * Meta   ：Piper Sandler将目标价从545美元上调至575美元              * 高通公司  ：Piper Sandler将目标价从185美元上调至205美元              * Silgan Holdings Inc   ：摩根大通将其评级从 \"减持 \"上调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBAY","SDGR","SNBR","BK4503","LU0444971666.USD","BK4079","IE00B4JS1V06.HKD","PAYC","CFLT","QDEL","LRCX","MTCH","CWAN","OBT","OMF","ALKT","BK4023","CDW","EVTC","LU1670627923.USD","META","LU1059921491.USD","CHRW","CIVB","XRAY","PTC","TDOC","SLGN","PLL","FORM","IE00BMPRXN33.USD","BMEA","GM","ATEC","ALXO","OVV","LU0198837287.USD","QTWO","SAGE","GKOS","LU1084165304.USD","COMP","AMWL","QCOM","BK4508","CNMD","BK4213","NTGR"],"gpt_icon":1},{"id":"2456930771","title":"Glaukos 公司报告截至六月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2456930771","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456930771?lang=zh_cn&edition=full","pubTime":"2024-08-01 05:01","pubTimestamp":1722459670,"startTime":"0","endTime":"0","summary":"   * Glaukos Corp   报告了截至6月底的季度调整后每股亏损52美分，高于去年同期的每股-55美分。13 位分析师对该季度的平均预期是每股亏损 51 美分。华尔街预期为每股-58 美分至-45 美分。* Glaukos 公司公布的本季度每股收益为亏损 1.06 美元。* 该公司当季亏损 5387 万美元。* Glaukos Corp本季度股价下跌了0.4%，今年迄今为止上涨了48.3%。华尔街对 Glaukos 公司 12 个月目标价的中位数为 120.00 美元。本摘要由 LSEG 7 月 31 日 09:00 p.m. UTC 调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","GKOS","BK4082","LU1878469433.USD","BK4548"],"gpt_icon":0},{"id":"2455199619","title":"Glaukos Corp   预计每股亏损51美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2455199619","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455199619?lang=zh_cn&edition=full","pubTime":"2024-07-30 04:58","pubTimestamp":1722286702,"startTime":"0","endTime":"0","summary":"   * Glaukos Corp    预计将在7月31日公布截至2024年6月30日的季度收入报告。* 根据LSEG的数据，12位分析师的平均预期显示，这家总部位于加利福尼亚州艾利索维埃霍的公司的营收将从去年同期的8040万美元增长10.6%，达到8889.5万美元。* LSEG分析师对Glaukos公司的平均预期是每股亏损51美分。* 华尔街对 Glaukos Corp 的 12 个月目标价中位数为 120.00 美元，高于其上次收盘价 119.69 美元。7月29日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GKOS"],"gpt_icon":0},{"id":"2452361854","title":"Glaukos Corporation盘中异动 急速跳水5.09%报117.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452361854","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452361854?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:31","pubTimestamp":1721316705,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时31分，Glaukos Corporation股票出现异动，股价急速下挫5.09%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为0.20%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。消息层面，截至23时31分，《大摩：维持Glaukos评级》资讯为影响Glaukos Corporation的重要信息。该信息摘要如下：大摩：维持Glaukos评级，由持股观望调整至持股观望评级,目标价由100.00美元调整至120.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718233145aefa5a06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718233145aefa5a06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009354923.USD","LU1878469433.USD","GKOS","BK4548","BK4082"],"gpt_icon":0},{"id":"2451990364","title":"Truist Securities：维持Glaukos(GKOS.US)评级，由买入调整至买入评级, 目标价由125.00美元调整至141.","url":"https://stock-news.laohu8.com/highlight/detail?id=2451990364","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451990364?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:38","pubTimestamp":1721137116,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4082","BK4548","LU1878469433.USD","GKOS","IE0009354923.USD"],"gpt_icon":0},{"id":"2451329986","title":"大摩：维持Glaukos(GKOS.US)评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2451329986","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451329986?lang=zh_cn&edition=full","pubTime":"2024-07-16 08:54","pubTimestamp":1721091273,"startTime":"0","endTime":"0","summary":"大摩：维持Glaukos(GKOS.US)评级，由持股观望调整至持股观望评级,目标价由100.00美元调整至120.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071609071895c40cd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071609071895c40cd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.glaukos.com","stockEarnings":[{"period":"1week","weight":0.0402},{"period":"1month","weight":0.1082},{"period":"3month","weight":0.0836},{"period":"6month","weight":0.3224},{"period":"1year","weight":1.2839},{"period":"ytd","weight":0.8115}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Glaukos Corporation，于1998年7月14日在美国特拉华州注册成立，是一个治疗青光眼的开发商，制造商和医疗设备商。该公司是一家眼科医疗技术公司，专注于设计、开发、改造和商业化治疗青光眼的突破性产品和程序，青光眼也是世界上引起失明的主要原因之一。该公司已率先微创青光眼手术，或MIGS，彻底改变了传统青光眼的治疗和管理模式。","yearOnYearQuotes":[{"month":1,"riseRate":0.888889,"avgChangeRate":0.091165},{"month":2,"riseRate":0.666667,"avgChangeRate":0.018112},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.005207},{"month":4,"riseRate":0.555556,"avgChangeRate":0.016877},{"month":5,"riseRate":0.555556,"avgChangeRate":0.027326},{"month":6,"riseRate":0.888889,"avgChangeRate":0.112367},{"month":7,"riseRate":0.7,"avgChangeRate":0.036945},{"month":8,"riseRate":0.4,"avgChangeRate":0.042947},{"month":9,"riseRate":0.4,"avgChangeRate":-0.020194},{"month":10,"riseRate":0.5,"avgChangeRate":-0.024992},{"month":11,"riseRate":0.5,"avgChangeRate":0.013104},{"month":12,"riseRate":0.444444,"avgChangeRate":0.004734}],"exchange":"NYSE","name":"Glaukos Corp","nameEN":"Glaukos"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Glaukos Corp(GKOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Glaukos Corp,GKOS,Glaukos Corp股票,Glaukos Corp股票老虎,Glaukos Corp股票老虎国际,Glaukos Corp行情,Glaukos Corp股票行情,Glaukos Corp股价,Glaukos Corp股市,Glaukos Corp股票价格,Glaukos Corp股票交易,Glaukos Corp股票购买,Glaukos Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Glaukos Corp(GKOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}